A vegetatively reproduced hemp (Cannabis sativa spp.) cultivar named ‘CAF#13/2020’ notable for its high cannabidiol (CBD) content, low Δ9-tetrahydrocannabinol (THC) content, and adaptation to growing conditions in Canada and the northern United States.

‘DKJ127’ is a Cannabis sativa cultivar suitable for production of herbal medicinal products (standardized extract) having high to very high THC content, about 17-20% THC eq.

‘DKJ127’ is a Cannabis sativa cultivar suitable for production of herbal medicinal products (standardized extract) having high to very high THC content, about 17-20% THC eq.

The unique annual herbaceous Cannabis plant variety ‘SW0’ is provided. The variety can be distinguished by its outstanding features.

The unique annual herbaceous Cannabis plant variety ‘Red KROSS02-BK’ is provided. The variety can be distinguished by its outstanding features as described.

The unique annual herbaceous Cannabis plant variety ‘Red KROSS02-BK’ is provided. The variety can be distinguished by its outstanding features as described.

A new and distinct variety of Cannabis sativa designated ‘PCT11204V’ as herein described and illustrated, characterized by elevated levels of THCV and other varin cannabinoids.

A new and distinct variety of Cannabis sativa designated ‘PCT11204V’ as herein described and illustrated, characterized by elevated levels of THCV and other varin cannabinoids.

This disclosure concerns a genetic platform for obtaining modified Cannabis plant materials exhibiting desirable novel chemotypes and agronomic traits, for example, by modulating the cannabinoid biosynthetic pathway.

This disclosure concerns a genetic platform for obtaining modified Cannabis plant materials exhibiting desirable novel chemotypes and agronomic traits, for example, by modulating the cannabinoid biosynthetic pathway.